Deregulated cyclin E induces chromosome instability (original) (raw)

References

  1. Dulic,V., Lees,E. & Reed,S. I. Association of human cyclin E with a periodic G1–S phase protein kinase. Science 257, 1958– 1961 (1992).
    Article ADS CAS Google Scholar
  2. Koff,A. et al. Formation and activation of a cyclin E-Cdk2 complex during the G1 phase of the cell cycle. Science 257, 1689–1694 (1992).
    Article ADS CAS Google Scholar
  3. Keyomarsi,K. & Herliczek,T. W. The role of cyclin E in cell proliferation, development and cancer. Prog. Cell Cycle Res. 3, 171–191 (1997).
    Article CAS Google Scholar
  4. Keyomarsi,K., Conte,D., Toyofuku,W. & Pat Fox,M. Deregulation of cyclin E in breast cancer. Oncogene 11, 941–950 (1995).
    CAS PubMed Google Scholar
  5. Dutta,A., Chandra,R., Leiter,L. M. & Lester,S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Natl Acad. Sci. USA 92, 5386– 5390 (1995).
    Article ADS CAS Google Scholar
  6. Porter,P. L. et al. Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222– 225 (1997).
    Article CAS Google Scholar
  7. Nielsen,N. H., Arnerlov,C., Cajander,S. & Landberg,G. Cyclin E expression and proliferation in breast cancer. Anal. Cell Pathol. 17, 177–188 (1998).
    Article CAS Google Scholar
  8. Dou, Q-P., Pardee,A. B. & Keyomarsi,K. Cyclin E—a better prognostic marker for breast cancer than cyclin D? Nature Med. 2, 254 (1996).
    Article Google Scholar
  9. Erlanson,M. et al. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92, 770–777 (1998).
    CAS PubMed Google Scholar
  10. Sakaguchi,T. et al. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 82, 1238– 1248 (1998).
    Article CAS Google Scholar
  11. Bito,T., Ueda,M., Ito,A. & Ichihashi,M. Less expression of cyclin E in cutaneous squamous cell carcinomas that in benign and premalignant keratinocytic lesions. J. Cutan. Pathol. 24, 305–308 (1997).
    Article CAS Google Scholar
  12. Bortner,D. M. & Rosenberg,M. P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol. 17, 453–459 (1997).
    Article CAS Google Scholar
  13. Hua,X. H., Yan,H. & Newport,J. A role for Cdk2 kinase in negatively regulating DNA replication during S phase of the cell cycle. J. Cell Biol. 137, 183 –192 (1997).
    Article CAS Google Scholar
  14. Walter,J., Sun,L. & Newport,J. Regulated chromosomal DNA replication in the absence of a nucleus. Mol. Cell 1, 519–529 ( 1998).
    Article CAS Google Scholar
  15. Hinchcliffe,E. H., Li,C., Thompson,E. A., Maller,J. L. & Sluder, G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283, 851–854 (1999).
    Article ADS CAS Google Scholar
  16. Lacey,K. R., Jackson,P. K. & Stearns, T. Cyclin-dependent kinase control of centrosome duplication. Proc. Natl Acad. Sci. USA 96, 2817– 2822 (1999).
    Article ADS CAS Google Scholar
  17. Gossen,M. & Bujard,H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA 89, 5547–5551 (1992).
    Article ADS CAS Google Scholar
  18. Resnitzky,D., Gossen,M., Bujard,H. & Reed,S. I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14, 1669–1679 (1994).
    Article CAS Google Scholar
  19. Won, K-A. & Reed,S. I. Activation of cyclin E/Cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15, 4182– 4193 (1996).
    Article Google Scholar
  20. Simpson,G., Roe,A. & Lewontin,R. Quantitative Zoology (Harcourt Brace, Burlingame, New York, 1960).
    MATH Google Scholar
  21. Lengauer,C., Kinzler,K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 ( 1998).
    Article ADS CAS Google Scholar
  22. Winey,M. Keeping the centrosome cycle on track. Genome stability. Curr. Biol. 6, 962–964 ( 1996).
    Article CAS Google Scholar
  23. Pihan,G. A. et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 58, 3974–3985 (1998).
    CAS PubMed Google Scholar
  24. Elble,R. & Tye,B. K. Chromosome loss, hyperrecombination, and cell cycle arrest in a yeast mcm1 mutant. Mol. Biol. Cell 9, 971–980 (1992).
    Article Google Scholar
  25. Mumberg,D. et al. Uncoupling of DNA replication and cell cycle progression by human cyclin E. Oncogene 13, 2493– 2497 (1996).
    CAS PubMed Google Scholar
  26. Haas,K. et al. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and Cdk4. Oncogene 15, 2615– 2623 (1997).
    Article CAS Google Scholar
  27. Resnitzky,D., Hengst,L. & Reed,S. I. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27kip1. Mol. Cell. Biol. 15, 4347– 4352 (1995).
    Article CAS Google Scholar
  28. Xu,X. et al. Centrosome amplifications and a defective G2–M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389–395 (1999).
    Article CAS Google Scholar

Download references